Treatment with BTZ alone or BTZ+suvecaltamide 30 mg/kg resulted in transient body weight loss during the first 2 weeks of treatment and no weight gain at days 18 and 28, consistent with the known anti-tumor and weight loss effects of BTZ in this model (Figure 7A). Here, CASC3 is linked to neoplasm.